Pang, H.Y.,
Chen, X.L.,
Song, X.H.,
Galiullin, D.,
Zhao, L.Y.,
Liu, K,
Zhang, W.H.,
Yang, K,
Chen, X.Z.,
Hu, J.K. (2021) , Web of Science, and the Cochrane Library was performed up to April 30, 2020. The primary
outcome and oligonucleotide primers.
Outcomings: Glutathion-S-transferase class π with A313G locus of AG heterozygous
Chatelain, Pierre,
Malievskiy, Oleg,
Radziuk, Klaudziya,
Senatorova, Ganna,
Abdou, Magdy O.,
Vlachopapadopoulou, Elpis,
Skorodok, Yulia,
Peterkova, Valentina,
Leff, Jonathan A.,
Beckert, Michael (2017) /kg/d for 26 weeks.
Main
Outcome Measures: GH and insulinlike growth factor-1 (IGF-1) levels, growth, adverse
Yunusbaeva, M.,
Borodina, L.,
Alekseev, P.,
Davydov, R.,
Sharipov, R.,
Bilalov, F.,
Yunusbayev, B. (2019) and treatment
outcomes of DSTB, MDR, and XDR-TB patients were analyzed. Results: Of 436 patients, 169 (39%) had
Wang, J.,
Fang, R.,
Wang, L.,
Chen, G.,
Wang, H.,
Wang, Z.,
Zhao, D.,
Pavlov, V.N.,
Kabirov, I.,
Wang, Z.,
Guo, P.,
Peng, L.,
Xu, W. (2018) was significantly higher in bladder cancer specimens than in normal tissue. The
outcome was similar in quantitative